Welcome to STAT’s Health Tech Tracker, a ledger of all the major data readouts, product launches, and regulatory happenings that industry observers should keep their eyes on in the next three months.
The fourth quarter, which starts on Thursday, closes out a year unlike any other for health tech, which has seen demand for its offerings surge amid the pandemic.
While biotech has a neatly scheduled list of make-or-break events — such as clinical trial results and drug approval decisions — to expect each quarter, health tech’s calendar follows a different rhythm. Yes, some digital health companies do tease data readouts, but, by and large, many of the biggest news events in health tech aren’t scheduled ahead of time — and may have a more nuanced effect on a company’s stock price or valuation.
